NCT07540572 2026-04-20
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
IDEAYA Biosciences
Phase 1/2 Recruiting
IDEAYA Biosciences
Pfizer
BeOne Medicines
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Seagen Inc.
Olema Pharmaceuticals, Inc.